|
此文章由 k200 原创或转贴,不代表本站立场和观点,版权归 oursteps.com.au 和作者 k200 所有!转贴必须注明作者、出处和本声明,并保持内容完整
是回复我这份询问的. 最后一段一个词, 指的是屠先生获得诺贝尔奖的青蒿
Dear Prof Adelson,
Thanks for your clarification. The following excerpt from Juice Daily is confusing to a layperson like me, and to the general readership I assume. Or maybe there was simply no time or need to delve deeper precisely because of the lack of biomedical knowledge/training on the part of average readers:
“The two plants contain different compounds and at present we don’t know which compounds or specific combination or ratio of these compounds are active against cancer cells. That work is the subject of ongoing research in my lab,” he says. http://www.juicedaily.com.au/new ... kills-cancer-cells/
If Zhengdong Group does disclose the composition, then it follows that your team knows the ‘ratio of these compounds’. Here again my assumption is that their disclosure will contain such info as the specific combination and ratio of the two herbs in every batch if not every capsule. The statement I quoted in the previous email seems to imply that their disclosure goes only as far as saying “the concentration is such that it meets our own standards.”
Some two decades prior to your studies, Zhendong claimed this two-herbs compound is indicated for ‘cancer pains and bleeding’ and, get this, “clearing heat, good for moisture, cooling the blood and purging the poison, unclogging the knot and alleviating the pain.” (“ 清热利湿,凉血解毒,散结止痛。用于癌肿疼痛、出血。”) One wonders how they knew the two herbs extract could do all that ( I will refrain from getting started on those TCM terms). From experimenting with thousands of plants and patients (I will not touch on the ethical issues here since we are talking China) or poring over ancient books (which would beg a bigger question)?
A more relevant question if I may please: given that ‘the most critical piece of evidence is the data one gets from well designed and controlled clinical trials in patients, how realistic is it in your opinion that your studies will be approved to advance to the ‘clinical trials in patients’ stage? Then again, that is a silly question. It has already been done, proved to be effective, and approved for sale and use--- in China. All this sounds a bit awkward: your studies, if successful, will only serve to add another, ‘overseas’ endorsement to something they’ve ‘known’ and done all along. Then again, who knows, there might be another ‘artemisinin’ and Nobel prize in there.
|
|